Discovery of Novel Leptospirosis Vaccine Candidates Using Reverse and Structural Vaccinology

Leptospira spp. are diderm (two membranes) bacteria that infect mammals causing leptospirosis, a public health problem with global implications. Thousands of people die every year due to leptospirosis, especially in developing countries with tropical climates. Prophylaxis is difficult due to multipl...

Full description

Bibliographic Details
Main Authors: Alan John Alexander McBride, André Alex Grassmann, Frederico Schmitt Kremer, Júlia Cougo dos Santos, Jéssica Dias Souza, Luciano da Silva Pinto
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2017.00463/full
_version_ 1811192706667380736
author Alan John Alexander McBride
Alan John Alexander McBride
André Alex Grassmann
Frederico Schmitt Kremer
Júlia Cougo dos Santos
Jéssica Dias Souza
Luciano da Silva Pinto
author_facet Alan John Alexander McBride
Alan John Alexander McBride
André Alex Grassmann
Frederico Schmitt Kremer
Júlia Cougo dos Santos
Jéssica Dias Souza
Luciano da Silva Pinto
author_sort Alan John Alexander McBride
collection DOAJ
description Leptospira spp. are diderm (two membranes) bacteria that infect mammals causing leptospirosis, a public health problem with global implications. Thousands of people die every year due to leptospirosis, especially in developing countries with tropical climates. Prophylaxis is difficult due to multiple factors, including the large number of asymptomatic hosts that transmit the bacteria, poor sanitation, increasing numbers of slum dwellers, and the lack of an effective vaccine. Several leptospiral recombinant antigens were evaluated as a replacement for the inactivated (bacterin) vaccine; however, success has been limited. A prospective vaccine candidate is likely to be a surface-related protein that can stimulate the host immune response to clear leptospires from blood and organs. In this study, a comprehensive bioinformatics approach based on reverse and structural vaccinology was applied toward the discovery of novel leptospiral vaccine candidates. The Leptospira interrogans serovar Copenhageni strain L1-130 genome was mined in silico for the enhanced identification of conserved β-barrel (βb) transmembrane proteins and outer membrane (OM) lipoproteins. Orthologs of the prospective vaccine candidates were screened in the genomes of 20 additional Leptospira spp. Three-dimensional structural models, with a high degree of confidence, were created for each of the surface-exposed proteins. Major histocompatibility complex II (MHC-II) epitopes were identified, and their locations were mapped on the structural models. A total of 18 βb transmembrane proteins and 8 OM lipoproteins were identified. These proteins were conserved among the pathogenic Leptospira spp. and were predicted to have epitopes for several variants of MHC-II receptors. A structural and functional analysis of the sequence of these surface proteins demonstrated that most βb transmembrane proteins seem to be TonB-dependent receptors associated with transportation. Other proteins identified included, e.g., TolC efflux pump proteins, a BamA-like OM component of the βb transmembrane protein assembly machinery, and the LptD-like LPS assembly protein. The structural mapping of the immunodominant epitopes identified the location of conserved, surface-exposed, immunogenic regions for each vaccine candidate. The proteins identified in this study are currently being evaluated for experimental evidence for their involvement in virulence, disease pathogenesis, and physiology, in addition to vaccine development.
first_indexed 2024-04-11T23:55:52Z
format Article
id doaj.art-052ce688a42e49c6b70f146113bf77b4
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-11T23:55:52Z
publishDate 2017-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-052ce688a42e49c6b70f146113bf77b42022-12-22T03:56:21ZengFrontiers Media S.A.Frontiers in Immunology1664-32242017-04-01810.3389/fimmu.2017.00463239599Discovery of Novel Leptospirosis Vaccine Candidates Using Reverse and Structural VaccinologyAlan John Alexander McBride0Alan John Alexander McBride1André Alex Grassmann2Frederico Schmitt Kremer3Júlia Cougo dos Santos4Jéssica Dias Souza5Luciano da Silva Pinto6Biotechnology Unit, Technological Development Center, Federal University of Pelotas, Pelotas, Rio Grande do Sul, BrazilGonçalo Moniz Institute, Oswaldo Cruz Foundation, Ministry of Health, Salvador, Bahia, BrazilBiotechnology Unit, Technological Development Center, Federal University of Pelotas, Pelotas, Rio Grande do Sul, BrazilBiotechnology Unit, Technological Development Center, Federal University of Pelotas, Pelotas, Rio Grande do Sul, BrazilBiotechnology Unit, Technological Development Center, Federal University of Pelotas, Pelotas, Rio Grande do Sul, BrazilBiotechnology Unit, Technological Development Center, Federal University of Pelotas, Pelotas, Rio Grande do Sul, BrazilBiotechnology Unit, Technological Development Center, Federal University of Pelotas, Pelotas, Rio Grande do Sul, BrazilLeptospira spp. are diderm (two membranes) bacteria that infect mammals causing leptospirosis, a public health problem with global implications. Thousands of people die every year due to leptospirosis, especially in developing countries with tropical climates. Prophylaxis is difficult due to multiple factors, including the large number of asymptomatic hosts that transmit the bacteria, poor sanitation, increasing numbers of slum dwellers, and the lack of an effective vaccine. Several leptospiral recombinant antigens were evaluated as a replacement for the inactivated (bacterin) vaccine; however, success has been limited. A prospective vaccine candidate is likely to be a surface-related protein that can stimulate the host immune response to clear leptospires from blood and organs. In this study, a comprehensive bioinformatics approach based on reverse and structural vaccinology was applied toward the discovery of novel leptospiral vaccine candidates. The Leptospira interrogans serovar Copenhageni strain L1-130 genome was mined in silico for the enhanced identification of conserved β-barrel (βb) transmembrane proteins and outer membrane (OM) lipoproteins. Orthologs of the prospective vaccine candidates were screened in the genomes of 20 additional Leptospira spp. Three-dimensional structural models, with a high degree of confidence, were created for each of the surface-exposed proteins. Major histocompatibility complex II (MHC-II) epitopes were identified, and their locations were mapped on the structural models. A total of 18 βb transmembrane proteins and 8 OM lipoproteins were identified. These proteins were conserved among the pathogenic Leptospira spp. and were predicted to have epitopes for several variants of MHC-II receptors. A structural and functional analysis of the sequence of these surface proteins demonstrated that most βb transmembrane proteins seem to be TonB-dependent receptors associated with transportation. Other proteins identified included, e.g., TolC efflux pump proteins, a BamA-like OM component of the βb transmembrane protein assembly machinery, and the LptD-like LPS assembly protein. The structural mapping of the immunodominant epitopes identified the location of conserved, surface-exposed, immunogenic regions for each vaccine candidate. The proteins identified in this study are currently being evaluated for experimental evidence for their involvement in virulence, disease pathogenesis, and physiology, in addition to vaccine development.http://journal.frontiersin.org/article/10.3389/fimmu.2017.00463/fullLeptospira interrogansouter membrane proteinepitope predictionbioinformaticstransport proteinsstructural modeling
spellingShingle Alan John Alexander McBride
Alan John Alexander McBride
André Alex Grassmann
Frederico Schmitt Kremer
Júlia Cougo dos Santos
Jéssica Dias Souza
Luciano da Silva Pinto
Discovery of Novel Leptospirosis Vaccine Candidates Using Reverse and Structural Vaccinology
Frontiers in Immunology
Leptospira interrogans
outer membrane protein
epitope prediction
bioinformatics
transport proteins
structural modeling
title Discovery of Novel Leptospirosis Vaccine Candidates Using Reverse and Structural Vaccinology
title_full Discovery of Novel Leptospirosis Vaccine Candidates Using Reverse and Structural Vaccinology
title_fullStr Discovery of Novel Leptospirosis Vaccine Candidates Using Reverse and Structural Vaccinology
title_full_unstemmed Discovery of Novel Leptospirosis Vaccine Candidates Using Reverse and Structural Vaccinology
title_short Discovery of Novel Leptospirosis Vaccine Candidates Using Reverse and Structural Vaccinology
title_sort discovery of novel leptospirosis vaccine candidates using reverse and structural vaccinology
topic Leptospira interrogans
outer membrane protein
epitope prediction
bioinformatics
transport proteins
structural modeling
url http://journal.frontiersin.org/article/10.3389/fimmu.2017.00463/full
work_keys_str_mv AT alanjohnalexandermcbride discoveryofnovelleptospirosisvaccinecandidatesusingreverseandstructuralvaccinology
AT alanjohnalexandermcbride discoveryofnovelleptospirosisvaccinecandidatesusingreverseandstructuralvaccinology
AT andrealexgrassmann discoveryofnovelleptospirosisvaccinecandidatesusingreverseandstructuralvaccinology
AT fredericoschmittkremer discoveryofnovelleptospirosisvaccinecandidatesusingreverseandstructuralvaccinology
AT juliacougodossantos discoveryofnovelleptospirosisvaccinecandidatesusingreverseandstructuralvaccinology
AT jessicadiassouza discoveryofnovelleptospirosisvaccinecandidatesusingreverseandstructuralvaccinology
AT lucianodasilvapinto discoveryofnovelleptospirosisvaccinecandidatesusingreverseandstructuralvaccinology